Medlive Technology Co Ltd
HKEX:2192
Intrinsic Value
Medlive Technology Co., Ltd. operates as an investment holding company. [ Read More ]
The intrinsic value of one
Medlive Technology Co Ltd
stock under the Base Case scenario is
5.42
HKD.
Compared to the current market price of 8.15 HKD,
Medlive Technology Co Ltd
is
Overvalued by 33%.
Medlive Technology Co Ltd's market price has consistently been higher than its intrinsic value.This persistent overvaluation suggests the market may be overly optimistic about
Medlive Technology Co Ltd or that its price is influenced by factors unrelated to fundamentals.
Medlive Technology Co Ltd's market capitalization is 5.9B HKD.
Medlive Technology Co Ltd stock price is 8.15 HKD.
Medlive Technology Co Ltd stock (5.42 HKD) is 33% less than its price (8.15 HKD).
Medlive Technology Co Ltd stock price (8.15 HKD) is 1% less than its DCF Value (8.22 HKD). Open DCF Valuation
Medlive Technology Co Ltd stock (2.63 HKD) is 68% less than its price (8.15 HKD). Open Relative Valuation
Medlive Technology Co Ltd has upside potential of 29% compared to the average analyst price target.
Open Wall St Estimates
Medlive Technology Co Ltd's ROE (Return on Equity) for the past 12 months is positive and is equal to 5%.
Medlive Technology Co Ltd's Revenue has grown by an exceptional 31% over the past 12 months.
Medlive Technology Co Ltd's Revenue is forecast to grow at a rate of 20% per year over the next 3 years.
Medlive Technology Co Ltd has a very low three-year average ROE (Return on Equity): 3%. The company is not efficient at transforming stockholders' equity into net income.
Medlive Technology Co Ltd has positive Operating Income for the last twelve months.
Medlive Technology Co Ltd has positive Net Income for the last twelve months.
Medlive Technology Co Ltd has positive Free Cash Flow for the last twelve months.
Medlive Technology Co Ltd's ROIC (Return on Invested Capital) for the past 12 months is very high and is equal to 59%.
Medlive Technology Co Ltd has very high three-year average ROIC (Return on Invested Capital): 28%. The company is very efficient at using invested capital to generate operating income.
Medlive Technology Co Ltd has positive Gross Profit for the last twelve months.
Medlive Technology Co Ltd's D/E (Debt to Equity) is very low and is equal to 0.
Medlive Technology Co Ltd's short-term assets (5B CNY) exceed its short-term liabilties (190m CNY).
Medlive Technology Co Ltd's long-term assets (5B CNY) exceed its long-term liabilties (296m CNY).
Medlive Technology Co Ltd has negative Net Debt. This means that the company has more cash and short-term investments (4B CNY) than debt (4m CNY).
Medlive Technology Co Ltd's Altman Z-Score is very high and is equal to 14.04.
Medlive Technology Co Ltd earns more than enough operating income (253m CNY) to safely cover interest payments on its debt (444k CNY).
Valuation Backtest
Medlive Technology Co Ltd
Run backtest to discover the historical profit from buying and selling
Medlive Technology Co Ltd
stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Medlive Technology Co Ltd
Balance Sheet Decomposition
Medlive Technology Co Ltd
| Current Assets | 4.6B |
| Cash & Short-Term Investments | 4.4B |
| Receivables | 155.9m |
| Other Current Assets | 15.8m |
| Non-Current Assets | 321.2m |
| Long-Term Investments | 42.4m |
| PP&E | 11.1m |
| Intangibles | 259.3m |
| Other Non-Current Assets | 8.5m |
| Current Liabilities | 189.8m |
| Accounts Payable | 14.8m |
| Other Current Liabilities | 175m |
| Non-Current Liabilities | 106.7m |
| Long-Term Debt | 3.6m |
| Other Non-Current Liabilities | 103m |
Earnings Waterfall
Medlive Technology Co Ltd
|
Revenue
|
412m
CNY
|
|
Cost of Revenue
|
-160.7m
CNY
|
|
Gross Profit
|
251.3m
CNY
|
|
Operating Expenses
|
2.2m
CNY
|
|
Operating Income
|
253.5m
CNY
|
|
Other Expenses
|
-11.2m
CNY
|
|
Net Income
|
242.3m
CNY
|
Free Cash Flow Analysis
Medlive Technology Co Ltd
Profitability Score
Profitability Due Diligence
Medlive Technology Co Ltd's profitability score is 67/100. The higher the profitability score, the more profitable the company is.
Score
Medlive Technology Co Ltd's profitability score is 67/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Medlive Technology Co Ltd's solvency score is 99/100. The higher the solvency score, the more solvent the company is.
Score
Medlive Technology Co Ltd's solvency score is 99/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Medlive Technology Co Ltd
According to Wall Street analysts, the average 1-year price target for
Medlive Technology Co Ltd
is 10.51 HKD
with a low forecast of 10.4 HKD and a high forecast of 10.82 HKD.
Shareholder Return
Price
Medlive Technology Co Ltd
| Average Annual Return | -40.5% |
| Standard Deviation of Annual Returns | 39.48% |
| Max Drawdown | -87% |
| Market Capitalization | 5.9B HKD |
| Shares Outstanding | 720 334 000 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
Medlive Technology Co Ltd
Country
Industry
Market Cap
Dividend Yield
Description
Medlive Technology Co., Ltd. operates as an investment holding company. The company is headquartered in Beijing, Beijing. The company went IPO on 2021-07-15. The firm mainly operates three segments. Its Precision Marketing and Corporate Solutions segment provides precision marketing solutions and corporate solutions. Its precision marketing solutions include digital detailing, digital marketing consulting and digital content creation services. Its revenue of its corporate solutions is primarily software as a service (SaaS). The Medical Knowledge Solutions segment mainly provides professional medical information and medical software services. The Intelligent Patient Management Solutions segment mainly provides online patient consultation and prescription services and patient management services. The firm mainly conducts its business within domestic market.
Contact
IPO
Employees
Officers
The intrinsic value of one
Medlive Technology Co Ltd
stock under the Base Case scenario is
5.42
HKD.
Compared to the current market price of 8.15 HKD,
Medlive Technology Co Ltd
is
Overvalued by 33%.
You don't have any saved screeners yet
